Nanomicelle-Based Redox-Responsive Dual-Prodrug for Synergistic Breast Cancer Chemo-Immunotherapy

Authors:

Abstract
No abstract available
Funding Information
  • National Key Research and Development Program of China (2022YFD1700200)
  • Dalian University of Technology (LD202027)
  • National Natural Science Foundation of China (22078050, 32171330)
  • Department of Health of Zhejiang Province (2022PY005, 2023RC138)
  • Liaoning Cancer Hospital and Institute (LD202027)
  • Shenyang Science and Technology Program (21-172-9-03)
  • Liaoning Livelihood of the People Science and Technology (2021JH2/10300061)

This publication has 53 references indexed in Scilit: